Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Saul

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Vaccine|October 20, 2006
The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trialsSouraya Ramjanee, James S Robertson, Blandine Franke-Fayard, et al.
Vaccine|January 26, 2006
Enhancement of functional antibody responses to AMA1-C1/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotideGregory E D Mullen, Birgitte K Giersing, Olubunmi Ajose-Popoola, et al.
Plos One|August 7, 2015
Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHBChristiane Gerke, Anna Maria Colucci, Carlo Giannelli, et al.
Plos Neglected Tropical Diseases|October 13, 2021
Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypesFrancesco Citiulo, Francesca Necchi, Francesca Mancini, et al.
Plos One|July 21, 2021
The introduction of a mandatory mask policy was associated with significantly reduced COVID-19 cases in a major metropolitan cityNick Scott, Allan Saul, Tim Spelman, et al.
The American Journal of Tropical Medicine and Hygiene|February 14, 2006
Assessment of transmission-blocking activity of candidate Pvs25 vaccine using gametocytes from chimpanzeesWilliam E Collins, John W Barnwell, Joann S Sullivan, et al.
Plos Neglected Tropical Diseases|March 5, 2015
Relationship between antibody susceptibility and lipopolysaccharide O-antigen characteristics of invasive and gastrointestinal nontyphoidal Salmonellae isolates from KenyaRobert S Onsare, Francesca Micoli, Luisa Lanzilao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2018
Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal <i>Salmonella</i>Francesca Micoli, Simona Rondini, Renzo Alfini, et al.
Plos One|June 16, 2012
High yield production process for Shigella outer membrane particlesFrancesco Berlanda Scorza, Anna Maria Colucci, Luana Maggiore, et al.
Plos Pathogens|March 21, 2015
An O antigen capsule modulates bacterial pathogenesis in Shigella sonneiMariaelena Caboni, Thierry Pédron, Omar Rossi, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Vaccine|October 20, 2006
The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trialsSouraya Ramjanee, James S Robertson, Blandine Franke-Fayard, et al.
Vaccine|January 26, 2006
Enhancement of functional antibody responses to AMA1-C1/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotideGregory E D Mullen, Birgitte K Giersing, Olubunmi Ajose-Popoola, et al.
Plos One|August 7, 2015
Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHBChristiane Gerke, Anna Maria Colucci, Carlo Giannelli, et al.
Plos Neglected Tropical Diseases|October 13, 2021
Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypesFrancesco Citiulo, Francesca Necchi, Francesca Mancini, et al.
Plos One|July 21, 2021
The introduction of a mandatory mask policy was associated with significantly reduced COVID-19 cases in a major metropolitan cityNick Scott, Allan Saul, Tim Spelman, et al.
The American Journal of Tropical Medicine and Hygiene|February 14, 2006
Assessment of transmission-blocking activity of candidate Pvs25 vaccine using gametocytes from chimpanzeesWilliam E Collins, John W Barnwell, Joann S Sullivan, et al.
Plos Neglected Tropical Diseases|March 5, 2015
Relationship between antibody susceptibility and lipopolysaccharide O-antigen characteristics of invasive and gastrointestinal nontyphoidal Salmonellae isolates from KenyaRobert S Onsare, Francesca Micoli, Luisa Lanzilao, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 29, 2018
Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal <i>Salmonella</i>Francesca Micoli, Simona Rondini, Renzo Alfini, et al.
Plos One|June 16, 2012
High yield production process for Shigella outer membrane particlesFrancesco Berlanda Scorza, Anna Maria Colucci, Luana Maggiore, et al.
Plos Pathogens|March 21, 2015
An O antigen capsule modulates bacterial pathogenesis in Shigella sonneiMariaelena Caboni, Thierry Pédron, Omar Rossi, et al.
Pageof 13